Bibliography

Export 1825 results:
Filters: Keyword is Human  [Clear All Filters]
N
Naglie G., Feldman S., Goldhar J., Katz P., Jackson L., Karuza J., Burello M., Woollard S., Calabrese S..  2015.  The integrated community care team: An innovative care model for frail seniors. Journal of the American Geriatrics Society. 63(SUPPL. 1):S75.
G
Giordano R., Villani E.R, Cipriani M.C, Onder G., Liperoti R..  2022.  Psychotropic medications and falls in nursing homes: Could frailty be a gamechanger? European Geriatric Medicine. 13(Supplement 1):S277.
H
Hoben M., Norton P.G, Ginsburg L.R, Anderson R.A, Cummings G.G, Lanham H.J, Squires J.E, Taylor D., Wagg A.S, Estabrooks C.A.  2017.  Improving Nursing Home Care through Feedback On PerfoRMance Data (INFORM): Protocol for a cluster-randomized trial. Trials. 18(1):nopagination.
D
Doupe M., Brunkert T., Wagg A., Ginsburg L., Norton P., Berta W., Knopp-Sihota J., Estabrooks C..  2022.  SCOPE: safer care for older persons (in residential) environments-a pilot study to enhance care aide-led quality improvement in nursing homes. Pilot and Feasibility Studies. 8(1):26.
M
Maxwell C.J, Campitelli M.A, Hogan D.B, Diong C., Austin P.C, Amuah J.E, Lapane K., Seitz D.P, Gill S.S, Gruneir A. et al..  2017.  Frailty, antipsychotics and mortality among community-based older adults with impaired cognition. Pharmacoepidemiology and Drug Safety. 26(Supplement 2):456-457.
Matlow J.N, Bronskill S.E, Gruneir A., Bell C.M, Stall N.M, Herrmann N., Seitz D.P, Gill S.S, Austin P.C, Fischer H.D et al..  2017.  Use of Medications of Questionable Benefit at the End of Life in Nursing Home Residents with Advanced Dementia. Journal of the American Geriatrics Society. 65(7):1535-1542.
G
Gilgen R..  1997.  [Assessment of need for nursing care]. Ther Umsch. 54(6):351-5.
S
Steel K., Jonsson P.V, DuPasquier J.N, Gilgen R., Hirdes J., Schroll M., Ljunggren G., Carpenter I., Bjørnson J..  1999.  Systems of care for frail older persons. InterRAI. Trans Am Clin Climatol Assoc. 110:30-5;discussion35-7.
B
Berg K., Sherwood S., Murphy K., Carpenter G.I, Gilgen R., Phillips C.D.  1997.  Rehabilitation in nursing homes: a cross-national comparison of recipients. Age & Ageing. 26(Suppl 2):37-42.
F
Fries B.E, Schroll M., Hawes C., Gilgen R., Jonsson P.V, Park P..  1997.  Approaching cross-national comparisons of nursing home residents. Age & Ageing. 26(Suppl 2):13-8.
G
Gilbart E.E, Hirdes J.P.  2000.  Stress, social engagement and psychological well-being in institutional settings: Evidence based on the minimum data set 2.0. Canadian Journal on Aging. 19(SUPPL. 2):50-66.
L
Landi F., Gambassi G., Lapane K.L, Sgadari A., Gifford D., Mor V., Bernabei R..  1998.  Comorbidity and drug use in cognitively impaired elderly living in long-term care. Dement Geriatr Cogn Disord. 9(6):347-56.
G
Gifford D.R, Lapane K.L, Gambassi G., Landi F., Mor V., Bernabei R..  1999.  Tacrine use in nursing homes: implications for prescribing new cholinesterase inhibitors. SAGE Study Group. Systematic Assessment of Geriatric Drug Use via Epidemiology.. Neurology. 52(2):238-44.
Giani T., Villani E.R, Palmer K., Onder G., Liperoti R..  2022.  Antipsychotic use and risk of death in older adults with cognitive impairment: The role of frailty. European Geriatric Medicine. 13(Supplement 1):S277-S278.
I
Ioannidis G., O'Donnell D., Kennedy C., Navare H., Giangregorio L.M, Cheung A.M, Marr S., Crilly R.G, Feldman S., Jain R. et al..  2015.  What triggers osteoporosis therapy in high risk residents living in long term care (LTC) homes? The gaining optimal osteoporosis assessments in long-term care (GOAL) study Osteoporosis International. 26(1 SUPPL. 1):S52-S53.
J
Jantzi M., Maher A.C, Ioannidis G., Hirdes J.P, Giangregorio L.M, Papaioannou A..  2015.  Individuals with neurological diseases are at increased risk of fractures within 180 days of admission to long-term care in Ontario. Age and Ageing. 44(2):252-257.
P
Papaioannou A., Jantzi M., Giangregorio L., Hirdes J., Adachi J.D, Ioannidis G..  2017.  A large number of frail older adults living in long term care homes are at high risk for hip fracture. Osteoporosis International. 28(Supplement 1):S632.
Papaioannou A., O'Donnell D., Kennedy C., Navare H., Giangregorio L., Marr S., Cheung A., Crilly R., Feldman S., Jain R. et al..  2015.  Risk factors that are associated with osteoporosis treatment in high risk residents living in long term care (LTC) homes? The gaining optimal osteoporosis assessments in long-term care (GOAL) study Journal of Bone and Mineral Research. 30(Supplement 1)
G
Gessert C.E, Curry N.M, Robinson A..  2001.  Ethnicity and end-of-life care: the use of feeding tubes. Ethn Dis. 11(1):97-106.
Gessert C.E, Mosier M.C, Brown E.F, Frey B..  2000.  Tube feeding in nursing home residents with severe and irreversible cognitive impairment. J Am Geriatr Soc. 48(12):1593-600.
W
Williams B.C, Fries B.E, Foley W.J, Schneider D., Gavazzi M..  1994.  Activities of daily living and costs in nursing homes. Health Care Financing Review. 15(4):117-35.
F
Fries B.E, Schneider D.P, Foley W.J, Gavazzi M., Burke R., Cornelius E..  1994.  Refining a case-mix measure for nursing homes: Resource Utilization Groups (RUG-III). Medical Care. 32(7):668-85.
B
Bernabei R., Gambassi G., Lapane K., Landi F., Gatsonis C., Dunlop R., Lipsitz L., Steel K., Mor V..  1998.  Management of pain in elderly patients with cancer. SAGE Study Group. Systematic Assessment of Geriatric Drug Use via Epidemiology. Jama. 279(23):1877-82.
Bernabei R., Gambassi G., Lapane K., Sgadari A., Landi F., Gatsonis C., Lipsitz L., Mor V..  1999.  Characteristics of the SAGE database: a new resource for research on outcomes in long-term care. SAGE (Systematic Assessment of Geriatric drug use via Epidemiology) Study Group. J Gerontol A Biol Sci Med Sci. 54(1):M25-33.
G
Gambassi G., Lapane K.L, Sgadari A., Carbonin P., Gatsonis C., Lipsitz L.A, Mor V., Bernabei R..  2000.  Effects of angiotensin-converting enzyme inhibitors and digoxin on health outcomes of very old patients with heart failure. SAGE Study Group. Systematic Assessment of Geriatric drug use via Epidemiology. Arch Intern Med. 160(1):53-60.